Fiche publication


Date publication

novembre 2010

Auteurs

Membres identifiés du Cancéropôle Est :
Dr MULLER Christian


Tous les auteurs :
Hulot C, Peluso J, Blond G, Muller CD, Suffert J

Résumé

New cyclooctatrienes were prepared by semihydrogenation of trienynes followed by 8pi electrocyclization. Cyclooctatrienes and original fenestrenes previously reported were tested for their pro-apoptotic activities on two human cancer cell lines (THP-1 and SW620). Among the 20 new compounds tested, two compounds presented specific activities on the colon carcinomas TRAIL-resistant metastatic cell SW620, but a minor action on the monocytic leukemia THP-1 cell line. Six other compounds showed cell type specific activities: four induced apoptosis only in THP-1 cells and two only in SW620. Such differential pro-apoptotic activities suggest that these molecules could serve as potent pharmacological tools to study TRAIL associated cellular mechanisms.

Référence

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6836-9